Drugs Made In America Acquisition Corp. (DMAA) Cash flow

2 Followers

Drugs Made In America Acquisition Corp. Cash Flow

DMAA's free cash flow for Q4 2025 was $-125.18K. For the 2025 fiscal year, DMAA's free cash flow was decreased by $-538.89K and operating cash flow was $-125.18K. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24
Operating Cash Flow	$ -539.19K	$ -295.00
Investing Cash Flow	$ -231.15M	$ 0.00
Financing Cash Flow	$ 231.69M	$ 173.62K
End Cash Position	$ 6.14K	$ 1.35K
Free Cash Flow	$ -539.19K	$ -295.00

Currency in USD